Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Nordic Journal of Psychiatry|September 24, 2016
Resistin as an inflammatory marker in patients with schizophrenia treated with clozapineJari-Pekka Klemettilä, Olli Kampman, Niko Seppälä, et al.Neuroscience Letters|August 15, 2009
TPH2 polymorphisms may modify clinical picture in treatment-resistant depressionSami Anttila, Merja Viikki, Kaija Huuhka, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 13, 2017
Histaminergic gene polymorphisms associated with sedation in clozapine-treated patientsAnssi Solismaa, Olli Kampman, Leo-Pekka Lyytikäinen, et al.The Journal of ECT|April 26, 2012
One-year follow-up after discontinuing maintenance electroconvulsive therapyKaija Huuhka, Merja Viikki, Tarja Tammentie, et al.Acta Neuropsychiatrica|January 10, 2018
BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depressionKadri Andre, Olli Kampman, Merja Viikki, et al.Acta Neuropsychiatrica|April 18, 2024
Polymorphisms in ERBB4 and TACR1 associated with dry mouth in clozapine-treated patientsHanna Puolakka, Anssi Solismaa, Leo-Pekka Lyytikäinen, et al.Human Psychopharmacology|August 29, 2014
Polymorphism in alpha 2A adrenergic receptor gene is associated with sialorrhea in schizophrenia patients on clozapine treatmentAnssi Solismaa, Olli Kampman, Niko Seppälä, et al.Journal of Clinical Psychopharmacology|April 6, 2018
Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving ClozapineAnssi Solismaa, Olli Kampman, Leo-Pekka Lyytikäinen, et al.BMC Psychiatry|April 20, 2013
TPH1 A218C polymorphism and temperament in major depressionKadri Andre, Olli Kampman, Merja Viikki, et al.Neuroscience Letters|July 12, 2011
Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDDMerja Viikki, Kaija Huuhka, Esa Leinonen, et al.Pageof 4